2024 Q1 Form 10-K Financial Statement
#000147793224001211 Filed on March 14, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | $5.000M | $12.00K | $12.00K |
YoY Change | |||
Cost Of Revenue | $0.00 | $0.00 | |
YoY Change | |||
Gross Profit | $5.000K | $12.00K | |
YoY Change | |||
Gross Profit Margin | 0.1% | 100.0% | |
Selling, General & Admin | $70.05K | $177.4K | $177.4K |
YoY Change | 815.69% | 2984.35% | 2984.35% |
% of Gross Profit | 1401.0% | 1477.92% | |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $70.68M | $178.2K | $196.3K |
YoY Change | 663783.15% | 1416.17% | 1369.44% |
Operating Profit | -$65.68M | -$184.3K | |
YoY Change | 616817.15% | 1279.61% | |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | -$54.50M | $0.00 | |
YoY Change | |||
Pretax Income | -$81.41K | -$166.2K | -$166.2K |
YoY Change | 664.41% | 1314.04% | 1143.64% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$120.2M | -$166.2K | -$184.3K |
YoY Change | 1128746.52% | 1314.04% | 1279.61% |
Net Earnings / Revenue | -2403.54% | -1384.58% | -1535.73% |
Basic Earnings Per Share | $0.00 | ||
Diluted Earnings Per Share | $0.00 | $0.00 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 63.75M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $4.020K | $19.70K | $19.70K |
YoY Change | 474.29% | 2714.29% | 2714.29% |
Cash & Equivalents | $4.022K | $19.70K | |
Short-Term Investments | |||
Other Short-Term Assets | $3.490K | $3.490K | $3.490K |
YoY Change | 0.0% | 0.0% | 0.0% |
Inventory | |||
Prepaid Expenses | $3.485K | $3.485K | |
Receivables | $5.000K | $5.000K | $5.000K |
Other Receivables | $40.00K | $40.00K | $40.00K |
Total Short-Term Assets | $52.51K | $68.18K | $68.18K |
YoY Change | 6.75% | 38.62% | 38.61% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $52.51K | $68.18K | $68.18K |
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $52.51K | $68.18K | $68.18K |
YoY Change | 6.75% | -99.98% | -99.98% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $4.000K | $4.000K | $4.000K |
YoY Change | 0.0% | 0.0% | 0.0% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $55.12K | $10.60K | $10.60K |
YoY Change | 634.93% | -100.0% | -100.0% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $222.1K | $177.1K | $79.91K |
YoY Change | 132.58% | -99.94% | -99.97% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $97.15K | $97.15K | |
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $97.15K | $97.15K |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $222.1K | $177.1K | $79.91K |
Total Long-Term Liabilities | $0.00 | $97.15K | $97.15K |
Total Liabilities | $222.1K | $177.1K | $182.9K |
YoY Change | 132.58% | -99.94% | -99.94% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$39.58M | -$39.46M | |
YoY Change | 0.75% | 0.47% | |
Common Stock | $697.0K | $637.5K | |
YoY Change | 39.39% | 27.49% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$169.6K | -$108.9K | -$114.7K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $52.51K | $68.18K | $68.18K |
YoY Change | 6.75% | -99.98% | -99.98% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$120.2M | -$166.2K | -$184.3K |
YoY Change | 1128746.52% | 1314.04% | 1279.61% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$75.18K | -$83.44K | -$118.5K |
YoY Change | -400.71% | 567.52% | 839.53% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | -$300.5M | $0.00 |
YoY Change | -100.0% | ||
Cash From Investing Activities | $0.00 | -$300.5M | $0.00 |
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $0.00 | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $59.50K | 300.5M | $137.5K |
YoY Change | -100.02% | 2404202.48% | |
NET CHANGE | |||
Cash From Operating Activities | -$75.18K | -83.44K | -$118.5K |
Cash From Investing Activities | $0.00 | -300.5M | $0.00 |
Cash From Financing Activities | $59.50K | 300.5M | $137.5K |
Net Change In Cash | -$15.68K | 4.360K | $19.00K |
YoY Change | 47938706971033490.0% | -17689.81% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$75.18K | -$83.44K | -$118.5K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
12000 | usd |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000055234 | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
63749525 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50004185 | shares |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
0-08962 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
KENILWORTH SYSTEMS CORPORATION | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
WY | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
84-1641415 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
721 Beach Street | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Daytona Beach | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
32114 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
312 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
372-6900 | |
CY2023 | dei |
Security12g Title
Security12gTitle
|
Common Stock, par value $.01 per share | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
1007485 | usd |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
63749525 | shares |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
5968 | |
CY2023 | dei |
Auditor Name
AuditorName
|
OLAYINKA OYEBOLA & CO. | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Lagos Nigeria | |
CY2023Q4 | us-gaap |
Cash
Cash
|
19699 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
702 | usd |
CY2023Q4 | kens |
Due From Related Party
DueFromRelatedParty
|
40000 | usd |
CY2022Q4 | kens |
Due From Related Party
DueFromRelatedParty
|
40000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
|
5000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
|
5000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
3485 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
3485 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
68184 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
49187 | usd |
CY2023Q4 | us-gaap |
Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
|
0 | usd |
CY2022Q4 | us-gaap |
Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
|
270450011 | usd |
CY2023Q4 | us-gaap |
Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
|
0 | usd |
CY2022Q4 | us-gaap |
Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
|
30000000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
68184 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
300499198 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4000 | usd |
CY2023Q4 | kens |
Due To Related Party Current
DueToRelatedPartyCurrent
|
104168 | usd |
CY2022Q4 | kens |
Due To Related Party Current
DueToRelatedPartyCurrent
|
48335 | usd |
CY2023Q4 | us-gaap |
Notes Payable
NotesPayable
|
68900 | usd |
CY2022Q4 | us-gaap |
Notes Payable
NotesPayable
|
300007500 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
177068 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
300059835 | usd |
CY2023Q4 | us-gaap |
Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
|
0 | usd |
CY2022Q4 | us-gaap |
Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
177068 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
300059835 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
63749525 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
50004185 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
637495 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
500042 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
38717734 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
39219146 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-39464238 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-39279950 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-108884 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
439363 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
68184 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
300499198 | usd |
CY2023 | us-gaap |
Revenues
Revenues
|
12000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2023 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
0 | usd |
CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
0 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
0 | usd |
CY2023 | kens |
Bank Charges Fees
BankChargesFees
|
797 | usd |
CY2022 | kens |
Bank Charges Fees
BankChargesFees
|
180 | usd |
CY2023 | us-gaap |
Professional Fees
ProfessionalFees
|
29817 | usd |
CY2022 | us-gaap |
Professional Fees
ProfessionalFees
|
5750 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
165674 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7500 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
196288 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
-13358 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-184288 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13358 | usd |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-184288 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13358 | usd |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.002 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.0003 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
447721 | usd |
CY2022 | kens |
Common Stock Issued During The Year Amount
CommonStockIssuedDuringTheYearAmount
|
5000 | usd |
CY2022 | kens |
Net Loss For The Year Amount
NetLossForTheYearAmount
|
26858 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13358 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
439363 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
439363 | usd |
CY2023 | kens |
Common Stock Issued During The Year Amount
CommonStockIssuedDuringTheYearAmount
|
-363959 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-184288 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-108884 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-184288 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-13358 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
-10000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
0 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | usd |
CY2023 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
-55832 | usd |
CY2022 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
5000 | usd |
CY2022 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
5750 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-118456 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-12608 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
137453 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12500 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
18997 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-108 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
702 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
810 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
19699 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
702 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
19699 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
702 | usd |
CY2023 | us-gaap |
Revenues
Revenues
|
12000 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-184288 | usd |